Jon T. Holmlund's most recent trade in Galera Therapeutics Inc was a trade of 75,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 28, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Galera Therapeutics Inc | Jon T. Holmlund | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Galera Therapeutics Inc | Jon T. Holmlund | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.43 per share. | 01 Sep 2021 | 47,756 | 47,756 (0%) | 0% | 2.4 | 116,047 | Common Stock |
| Galera Therapeutics Inc | Jon T. Holmlund | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2021 | 47,756 | 61,142 | - | - | Stock Option | |
| Galera Therapeutics Inc | Jon T. Holmlund | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 8.47 per share. | 01 Sep 2021 | 47,756 | 0 (0%) | 0% | 8.5 | 404,498 | Common Stock |
| Galera Therapeutics Inc | Jon T. Holmlund | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 71,250 | 71,250 | - | - | Stock Option (Right to Buy) | |
| Galera Therapeutics Inc | Jon T. Holmlund | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.43 per share. | 26 Oct 2020 | 2,244 | 2,244 (0%) | 0% | 2.4 | 5,453 | Common Stock |
| Galera Therapeutics Inc | Jon T. Holmlund | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Oct 2020 | 2,244 | 108,898 | - | - | Stock Option | |
| Galera Therapeutics Inc | Jon T. Holmlund | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 26 Oct 2020 | 2,244 | 0 (0%) | 0% | 15 | 33,660 | Common Stock |
| Galera Therapeutics Inc | Jon T. Holmlund | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 12.00 per share. | 05 Oct 2020 | 10,536 | 0 (0%) | 0% | 12 | 126,432 | Common Stock |
| Galera Therapeutics Inc | Jon T. Holmlund | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Oct 2020 | 5,632 | 0 | - | - | Stock Option | |
| Galera Therapeutics Inc | Jon T. Holmlund | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.14 per share. | 05 Oct 2020 | 5,632 | 5,632 (0%) | 0% | 1.1 | 6,420 | Common Stock |
| Galera Therapeutics Inc | Jon T. Holmlund | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Oct 2020 | 4,904 | 0 | - | - | Stock Option | |
| Galera Therapeutics Inc | Jon T. Holmlund | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.07 per share. | 05 Oct 2020 | 4,904 | 4,904 (0%) | 0% | 1.1 | 5,247 | Common Stock |
| Galera Therapeutics Inc | Jon T. Holmlund | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.07 per share. | 05 Oct 2020 | 100 | 100 (0%) | 0% | 1.1 | 107 | Common Stock |
| Galera Therapeutics Inc | Jon T. Holmlund | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 12.00 per share. | 05 Oct 2020 | 100 | 0 (0%) | 0% | 12 | 1,200 | Common Stock |
| Galera Therapeutics Inc | Jon T. Holmlund | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Oct 2020 | 100 | 4,904 | - | - | Stock Option |